Israel is the first country in patent per inhabitant. Here, R&D is the watchword! 4% of the GDP is reinvested each year in R&D, which is why Israel deserves its surname of “startup nation”.
Innovative ideas are today’s main resource in the world of startups and biotechs, but development and implementation is the key. RGL Research offers you the opportunity to maximize your recruitment objectives, by involving the best sites with high expertise staff. RGL accompanies your product into the heart of clinical development by being in the front line from the early stages to the commercialization.
Based in Israel, RGL team offers you the possibility to optimize your start-up timelines and cost-effectiveness, with the highest sites and staff expertise. As a result, we accompany pharmaceutical companies into the long journey of development by being in the front line from your feasibility phase to the commercialization of your new products.